Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy

Overview of attention for article published in Frontiers in immunology, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 8 X users

patent: 2 patents

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 50,101 followers.

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy https://t.co/ttHrFc8ECw

09 Apr 2021

Reply Repost Favourite

2/ Lacutamab for refractory orphan disease (Sezary). Great preclinical work on their 1st in class Anti-NKG2A mab: https://t.co/Gz3jz9K5pi https://t.co/znTiy5YD9u Appears to have synergy with other IOs. AZN partnered to provide Durva. https://t.co/3XYupcmP

15 Nov 2020

Reply Repost Favourite

RT @efaithd: Human NK cells also express CTLA-4 and bind anti-CTLA-4 antibodies independent of FcR, indicating that "blockade" may have imp…

30 Jul 2020

Reply Repost Favourite

Human NK cells also express CTLA-4 and bind anti-CTLA-4 antibodies independent of FcR, indicating that "blockade" may have important consequences to the anti tumor activity of NK cells as well! @allisonoconn https://t.co/AG2gj4gk9V

30 Jul 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.